Li Jingyang increased his holding of Huakang Biomed (08622) by approximately 139 million shares, with a price of 0.1175 Hong Kong dollars per share.
On January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, with a price of 0.1175 Hong Kong dollars per share, for a total amount of 16.29396 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, at a price of HK$0.1175 per share, for a total amount of HK$16.29396 million. After the increase, the latest number of shares held is 138.672 million, with a latest shareholding percentage of 27.71%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
